Glycan-interacting Compounds

Abstract

The present invention provides glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives and fragments thereof as well as compositions and kits comprising them.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Aug 16, 2016
  • Application: Jan 21, 2016
    US US 201615002674 A
  • Priority: Jan 21, 2016
    US US 201615002674 A
  • Priority: Oct 10, 2013
    US US 201314050773 A
  • Priority: Mar 6, 2013
    US US 2013/0029240 W
  • Priority: Apr 4, 2012
    US US 201261620414 P

Download Citation


Sign in to the Lens

Feedback